Live Breaking News & Updates on Degrees pharmaceuticals inc

Stay informed with the latest breaking news from Degrees pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Degrees pharmaceuticals inc and stay connected to the pulse of your community

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Sees Significant Growth in Short Interest

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 130,700 shares, a growth of 95.1% from the March 31st total of 67,000 shares. Currently, 1.5% of the shares of the company […]

United-states , Tafenoquine-arakoda , Degrees-pharmaceuticals-daily , Degrees-pharmaceuticals-inc , Nasdaq , Degrees-pharmaceuticals , Degrees-pharmaceuticals-price-performance , Get-free-report , Pharmaceuticals-price , Pharmaceuticals-daily , 60-degrees-pharmaceuticals , Nasdaq-sxtp

60 Degrees Pharmaceuticals to Sponsor Pilot Study of

60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....

Australia , Washington , United-states , Australian , Patrick-gaynes , Sheilaa-burke , United-states-army , Exchange-commission , Materiel-development-activity , Degrees-pharmaceuticals-inc , Drug-administration , Degrees-pharmaceuticals

60 Degrees Pharmaceuticals (SXTP) to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

60 Degrees Pharmaceuticals (SXTP) to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , United-states , Carolina-state-university , Degrees-pharmaceuticals , Walter-reed-army-institute-of-research , Drug-administration , United-states-army-medical-materiel-development-activity , Degrees-pharmaceuticals-inc , Nasdaq , Canine-babesiosis-pilot-studythe , Institutional-animal-care

Short Interest in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Decreases By 56.9%

Short Interest in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Decreases By 56.9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Tafenoquine-arakoda , Walleye-capital , Nasdaq , Degrees-pharmaceuticals-company-profile , Exchange-commission , Degrees-pharmaceuticals-inc , Degrees-pharmaceuticals-price-performance , Degrees-pharmaceuticals-daily , Degrees-pharmaceuticals , Get-free-report , Free-report

Short Interest in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Decreases By 56.9%

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 65,500 shares, a decline of 56.9% from the February 29th total of 152,000 shares. Approximately 1.5% of the company’s shares are short […]

United-states , Tafenoquine-arakoda , Exchange-commission , Walleye-capital , Nasdaq , Degrees-pharmaceuticals-price-performance , Degrees-pharmaceuticals-inc , Degrees-pharmaceuticals-daily , Degrees-pharmaceuticals , Get-free-report , Pharmaceuticals-price , Free-report

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data sup...

Joseph-reda , David-lazar , Maxwell-skor , Jamie-khoo , Intelligent-group-limited , Cap-ltd , Tivic-health-systems-inc , Degrees-pharmaceuticals-inc , Greenwave-technology-solutions , Morgan-stanley , Greenwave-technology-solutions-inc , Buzzfeed-inc

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Westport Fuel Systems (NASDAQ:WPRT)

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

United-states , Italy , Maxwell-skor , Tesla-inc , Canoo-inc , David-lazar , Joseph-feldman , Equillium-inc , Reddit-inc , Graphjet-technology , Cardlytics-inc , Nuvation-bio-inc

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.6%

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.6%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states , Tafenoquine-arakoda , Degrees-pharmaceuticals-price-performance , Nasdaq , Degrees-pharmaceuticals-inc , Degrees-pharmaceuticals-daily , Securities-exchange-commission , Degrees-pharmaceuticals , Walleye-capital , Get-free-report , Pharmaceuticals-price , Free-report

Short Interest in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Drops By 50.5%

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) saw a large drop in short interest in February. As of February 15th, there was short interest totalling 255,300 shares, a drop of 50.5% from the January 31st total of 515,700 shares. Based on an average daily trading volume, of 764,700 shares, the short-interest ratio is […]

United-states , Tafenoquine-arakoda , Securities-exchange-commission , Walleye-capital , Nasdaq , Degrees-pharmaceuticals-stock-performance , Degrees-pharmaceuticals-company-profile , Degrees-pharmaceuticals , Degrees-pharmaceuticals-daily , Degrees-pharmaceuticals-inc , Get-free-report , Pharmaceuticals-stock

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris

Candida auris (C. auris) is a dangerous drug-resistant fungal pathogen emerging in U.S. hospitalsTafenoquine’s presumed mode of action against C. auris is differentiated from standard of care treatmentMonash University will conduct the studies beginning in second quarter of 2024 WASHINGTON, Feb. 20, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company,” “60P” or “60 Degrees Pharmaceuticals”) (NASDAQ: SXTP; SXTPW), specialists in developing and marketing medicines for infectiou

United-states , Singapore , Central-school , Washington , Monash , South-australia , Australia , Melbourne , Victoria , Canada , Australian , American